scPharmaceuticals Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
scPharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2024.
  • scPharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $15K.
  • scPharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $14.9M, a 80.8% decline from 2022.
  • scPharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $77.2M.
  • scPharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$2.53M, a 104% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $15K* -$13.7M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $13.7M +$16.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 -$2.48M -$2.41M -3343% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 -$72K -$10.5M -101% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $10.5M +$10.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $18K* -$38K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $56K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.